Market Insights Health Pharmaceuticals Vaccines

COVID-19 Vaccines - Denmark

Denmark

Denmark is projected to witness a significant growth in revenue within the COVID-19 Vaccines market.
By the year 2024, the revenue is estimated to reach US$51,150.00k.
This growth is anticipated to continue with an annual growth rate of -18.04% from 2024 to 2029, resulting in a market volume of US$18,920.00k by 2029.
It is important to note that these figures are specific to in Denmark.
In comparison to other countries, United States is expected to generate the highest revenue within the global market.
In 2024 alone, the revenue United States is projected to reach a staggering US$4,389,000.00k.
This showcases the substantial market potential and opportunities that lie within the COVID-19 Vaccines market on a global scale.
In Denmark, the demand for COVID-19 vaccines is high, with a significant portion of the population actively seeking vaccination.

Key regions: United Kingdom, Germany, France, South Korea, Italy

Market

Region

Region comparison

Currency

Analyst Opinion

Denmark, a small country in Northern Europe, has been making significant progress in the COVID-19 vaccination campaign. As of now, the country has vaccinated a considerable percentage of its population, and the demand for vaccines is still high. The COVID-19 Vaccines market in Denmark is developing at a steady pace, and several factors are contributing to this growth.

Customer preferences: The Danish population has shown a high level of trust in vaccines, and they are willing to get vaccinated. The government has also been proactive in communicating the benefits of vaccination, which has further increased the demand for vaccines. A significant percentage of the population prefers to get vaccinated with the Pfizer-BioNTech vaccine due to its high efficacy rate.

Trends in the market: One of the notable trends in the COVID-19 Vaccines market in Denmark is the increasing demand for booster shots. The government has announced plans to offer booster shots to the elderly and vulnerable population, and this has led to a surge in demand for vaccines. Another trend is the increasing availability of vaccines in pharmacies and clinics, making it more convenient for people to get vaccinated.

Local special circumstances: Denmark has a well-developed healthcare system, and the government has been proactive in securing vaccine supplies. The country has also been successful in managing the pandemic, which has led to a high level of confidence among the population. The government has also been transparent in its communication about the vaccination campaign, which has further increased trust in the vaccines.

Underlying macroeconomic factors: Denmark has a strong economy, and the government has allocated significant resources towards the vaccination campaign. The country has also been successful in controlling the spread of the virus, which has led to a faster economic recovery. The government's proactive approach towards vaccination has also helped in reducing the impact of the pandemic on the economy.In conclusion, the COVID-19 Vaccines market in Denmark is developing at a steady pace, driven by high customer demand and the government's proactive approach towards vaccination. The increasing availability of vaccines and the demand for booster shots are some of the notable trends in the market. Denmark's well-developed healthcare system, strong economy, and successful management of the pandemic are the underlying macroeconomic factors contributing to the growth of the market.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.